These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23032887)

  • 61. Second cancers following radiotherapy: a suggested common dosimetry framework for therapeutic and concomitant exposures.
    Harrison RM
    Br J Radiol; 2004 Dec; 77(924):986-90. PubMed ID: 15569639
    [No Abstract]   [Full Text] [Related]  

  • 62. Therapy-associated solid tumors.
    Travis LB
    Acta Oncol; 2002; 41(4):323-33. PubMed ID: 12234023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Solid tumor second primary neoplasms: who is at risk, what can we do?
    Oeffinger KC; Baxi SS; Novetsky Friedman D; Moskowitz CS
    Semin Oncol; 2013 Dec; 40(6):676-89. PubMed ID: 24331190
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiation Therapy Technology Advances and Mitigation of Subsequent Neoplasms in Childhood Cancer Survivors.
    Stokkevåg CH; Journy N; Vogelius IR; Howell RM; Hodgson D; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):681-696. PubMed ID: 38430101
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Models for the risk of secondary cancers from radiation therapy.
    Dasu A; Toma-Dasu I
    Phys Med; 2017 Oct; 42():232-238. PubMed ID: 28242139
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intensity Modulated Radiation Therapy and Second Cancer Risk in Adults.
    Filippi AR; Vanoni V; Meduri B; Cozzi L; Scorsetti M; Ricardi U; Lohr F
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):17-20. PubMed ID: 29254772
    [No Abstract]   [Full Text] [Related]  

  • 67. Impediments to Comparative Clinical Trials With Proton Therapy.
    Cox JD
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):4-8. PubMed ID: 26684408
    [No Abstract]   [Full Text] [Related]  

  • 68. Second cancer risk, concomitant exposures and IRMER(2000).
    Aird EG
    Br J Radiol; 2004 Dec; 77(924):983-5. PubMed ID: 15569638
    [No Abstract]   [Full Text] [Related]  

  • 69. The Role of Particle Therapy in the Risk of Radio-induced Second Tumors: A Review of the Literature.
    Facoetti A; Barcellini A; Valvo F; Pullia M
    Anticancer Res; 2019 Sep; 39(9):4613-4617. PubMed ID: 31519558
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Second malignancies developing after treatment for paediatric cancers.
    Smee R
    Australas Radiol; 1995 Nov; 39(4):335-6. PubMed ID: 8561705
    [No Abstract]   [Full Text] [Related]  

  • 71. Radiotherapy-induced second cancers: are we doing enough to protect young patients?
    Epstein R; Hanham I; Dale R
    Eur J Cancer; 1997 Apr; 33(4):526-30. PubMed ID: 9274430
    [No Abstract]   [Full Text] [Related]  

  • 72. Proton beam irradiation in pediatric oncology: an overview.
    Wilson VC; McDonough J; Tochner Z
    J Pediatr Hematol Oncol; 2005 Aug; 27(8):444-8. PubMed ID: 16096529
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NCI reports on risks of new cancers in survivors.
    Young D
    Am J Health Syst Pharm; 2007 Mar; 64(5):454-6. PubMed ID: 17322154
    [No Abstract]   [Full Text] [Related]  

  • 74. Myths and realities of range uncertainty.
    Lomax AJ
    Br J Radiol; 2020 Mar; 93(1107):20190582. PubMed ID: 31778317
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 12. Cancers in 2010 attributable to ionising radiation exposure in the UK.
    Parkin DM; Darby SC
    Br J Cancer; 2011 Dec; 105 Suppl 2(Suppl 2):S57-65. PubMed ID: 22158322
    [No Abstract]   [Full Text] [Related]  

  • 76. Anticancer therapies associated with secondary cutaneous malignancies: A review of the literature.
    Deutsch A; Balagula Y; McLellan BN
    J Am Acad Dermatol; 2020 Nov; 83(5):1425-1433. PubMed ID: 32334055
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modelling the influence of radiosensitivity on development of second primary cancer in out-of-field organs following proton therapy for paediatric cranial cancer.
    Dell'Oro M; Wilson P; Short M; Peukert D; Bezak E
    Br J Radiol; 2023 Oct; 96(1150):20230161. PubMed ID: 37660473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Second tumours.
    Meadows AT
    Eur J Cancer; 2001 Nov; 37(16):2074-9; discussion 2079-81. PubMed ID: 11597387
    [No Abstract]   [Full Text] [Related]  

  • 79. Assessing the risk of second malignancies after modern radiotherapy.
    Newhauser WD; Durante M
    Nat Rev Cancer; 2011 Jun; 11(6):438-48. PubMed ID: 21593785
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk of second malignancy after modern conformal and proton beam radiotherapy-Minimizing risks, improving survivorshipInstructions to authors and other literary works of fiction.
    Chilukuri S; Jalali R
    Indian J Cancer; 2018; 55(4):316-317. PubMed ID: 30829263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.